• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[川楝止咳注射液中淫羊藿苷A、B、C及淫羊藿苷在大鼠体内的药代动力学]

[Pharmacokinetics of epimedin A, B, C and icariin of Chuankezhi injection in rat].

作者信息

Xu Shun-Jun, Zhu Ya-Ling, Yu Jie-Jing, Sun Shuai, Xu Yi-Juan, Yang Liu

机构信息

Guangzhou ImVin Pharmaceutical Co., Ltd., Guangzhou 510663, China.

Guangdong Second Traditional Chinese Medicine Hospital, Guangzhou 510095, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2016 Jan;41(1):129-133. doi: 10.4268/cjcmm20160125.

DOI:10.4268/cjcmm20160125
PMID:28845654
Abstract

To study pharmacokinetic characteristics of epimedin A, B, C and icariin after intermuscular administration of Chuankezhi injection to rat. The established RRLC-MS/MS method was applied for simultaneous determination of four analytes in rat plasma and calculating their pharmacokinetic parameters. As a result, each analyte showed a good linear relationship in the concentration range of 1-1 000 μg•L⁻¹.The intra-day precise was 96.9%-107.5% with RSD<5.99%, inter-day precise was 92.3%-105.0% with RSD<10.16%. The relative recovery of four analytes was 88.1%-101.1% with RSD<7.9% and their absolute recovery was 72.0%-86.6% with RSD<6.3%. After intermuscular administration of Chuankezhi injection, the plasma concentration of four flavonoid glycosides rapidly arose to peaks at about 10 min, and then quickly declined in rat. Tmax of epimedin A, B, C and icariin was 0.21, 0.19, 0.16 and 0.49 h, respectively, and their mean elimination half-life(t1/2z) was 0.60, 0.62, 0.47 and 0.49 h. The established method was validated to be sensitive, rapid and specific for determination of the four analytes. Serum concentration of 4 species of epimedium flavonoids in Chuankezhi injection was low, and their absorption and elimination seem quickly, displaying similar pharmacokinetic characteristics in this study.

摘要

研究穿琥宁注射液肌肉注射给药后大鼠体内淫羊藿苷A、B、C及淫羊藿苷的药代动力学特征。采用所建立的快速液相色谱-串联质谱(RRLC-MS/MS)法同时测定大鼠血浆中4种分析物,并计算其药代动力学参数。结果显示,各分析物在1~1000μg•L⁻¹浓度范围内呈良好的线性关系。日内精密度为96.9%~107.5%,相对标准偏差(RSD)<5.99%;日间精密度为92.3%~105.0%,RSD<10.16%。4种分析物的相对回收率为88.1%~101.1%,RSD<7.9%;绝对回收率为72.0%~86.6%,RSD<6.3%。穿琥宁注射液肌肉注射给药后,4种黄酮苷的血浆浓度在约10min迅速升至峰值,随后在大鼠体内迅速下降。淫羊藿苷A、B、C及淫羊藿苷的达峰时间(Tmax)分别为0.21、0.19、0.16和0.49h,其平均消除半衰期(t1/2z)分别为0.60、0.62、0.47和0.49h。所建立的方法经验证对4种分析物的测定具有灵敏、快速和特异的特点。穿琥宁注射液中4种淫羊藿黄酮的血清浓度较低,其吸收和消除较快,在本研究中显示出相似的药代动力学特征。

相似文献

1
[Pharmacokinetics of epimedin A, B, C and icariin of Chuankezhi injection in rat].[川楝止咳注射液中淫羊藿苷A、B、C及淫羊藿苷在大鼠体内的药代动力学]
Zhongguo Zhong Yao Za Zhi. 2016 Jan;41(1):129-133. doi: 10.4268/cjcmm20160125.
2
[Simultaneous determination of 4 prenylflavonoids of Chuankezhi injection in rat plasma by LC-MS/MS].[LC-MS/MS法同时测定大鼠血浆中喘可治注射液的4种异戊烯基黄酮类成分]
Yao Xue Xue Bao. 2016 Apr;51(4):637-41.
3
Pharmacokinetics and oral bioavailability of epimedin C after oral administration of epimedin C and Herba Epimedii extract in rats.大鼠口服淫羊藿苷和淫羊藿提取物后淫羊藿苷的药代动力学及口服生物利用度
Biomed Chromatogr. 2014 May;28(5):630-6. doi: 10.1002/bmc.3081. Epub 2013 Nov 21.
4
Pipette tip solid-phase extraction and high-performance liquid chromatography for the determination of flavonoids from Epimedii herba in rat serum and application of the technique to pharmacokinetic studies.移液器吸头固相萃取-高效液相色谱法测定大鼠血清中淫羊藿黄酮及其在药代动力学研究中的应用
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 May 15;990:64-72. doi: 10.1016/j.jchromb.2015.03.012. Epub 2015 Mar 23.
5
[Comparative study on absorption kinetics in intestines of rats of epimedii foliunm of Xianlinggubao capsules prepared by different processes].[不同工艺制备的仙灵骨葆胶囊中淫羊藿叶在大鼠肠道吸收动力学的比较研究]
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(19):2648-52.
6
Intestinal Absorption and Metabolism of Epimedium Flavonoids in Osteoporosis Rats.骨质疏松大鼠对淫羊藿黄酮的肠道吸收与代谢
Drug Metab Dispos. 2015 Oct;43(10):1590-600. doi: 10.1124/dmd.115.064386. Epub 2015 Jul 1.
7
Development and Validation of a HPLC-MS/MS Method for Simultaneous Determination of Twelve Bioactive Compounds in : Application to a Pharmacokinetic Study in Rats.建立并验证一种高效液相色谱-串联质谱法同时测定 中 12 种生物活性化合物的含量:应用于大鼠体内药代动力学研究。
Molecules. 2018 May 31;23(6):1322. doi: 10.3390/molecules23061322.
8
[Absorption and metabolism of flavonoids in Herba Epimedii via rat intestinal perfusion model].[基于大鼠肠道灌注模型的淫羊藿中黄酮类化合物的吸收与代谢]
Zhongguo Zhong Yao Za Zhi. 2009 Nov;34(22):2928-31.
9
Simultaneous determination of 15 flavonoids in Epimedium using pressurized liquid extraction and high-performance liquid chromatography.采用加压液体萃取和高效液相色谱法同时测定淫羊藿中15种黄酮类化合物。
J Chromatogr A. 2007 Sep 7;1163(1-2):96-104. doi: 10.1016/j.chroma.2007.06.020. Epub 2007 Jun 17.
10
Simultaneous determination of two iridoid glycosides, two anthraquinones and four flavonoid glycosides of Zhi-Zi-Da-Huang decoction in rat plasma by UFLC-MS/MS: application to a comparative pharmacokinetic study in normal and cholestatic liver injury rats.采用 UFLC-MS/MS 同时测定大鼠血浆中栀子大黄汤的两种环烯醚萜苷、两种蒽醌和四种黄酮苷:在正常和胆汁淤积性肝损伤大鼠中的比较药代动力学研究的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 1;960:116-25. doi: 10.1016/j.jchromb.2014.04.031. Epub 2014 Apr 24.

引用本文的文献

1
Evidence Construction of Chuankezhi Injection Against Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Pharmacology.喘可治注射液治疗慢性阻塞性肺疾病的证据构建:系统评价及网络药理学研究。
Int J Chron Obstruct Pulmon Dis. 2024 May 27;19:1177-1196. doi: 10.2147/COPD.S442281. eCollection 2024.
2
New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action.喘可治注射液治疗激素抵抗型局灶节段性肾小球硬化的新适应症及其作用机制
Ann Transl Med. 2022 Jun;10(11):639. doi: 10.21037/atm-22-1962.
3
Efficacy and safety of Chuankezhi injection in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis protocol.
喘可治注射液治疗慢性阻塞性肺疾病患者的疗效与安全性:一项系统评价和Meta分析方案
Medicine (Baltimore). 2020 Jan;99(2):e18620. doi: 10.1097/MD.0000000000018620.